{"variables":{"72":{"years":[],"entities":[],"values":[],"id":72,"name":"Total population (Gapminder)","unit":"","description":"","createdAt":"2015-07-23T03:52:31.000Z","updatedAt":"2018-02-28T08:58:29.000Z","code":null,"coverage":"","timespan":"","datasetId":70,"sourceId":301,"shortUnit":null,"display":{},"columnOrder":0,"datasetName":"Total population - Gapminder","s_id":301,"s_name":"Gapminder","source":{"id":301,"name":"Gapminder","dataPublishedBy":"","dataPublisherSource":"","link":"http://www.gapminder.org/","retrievedData":"","additionalInfo":"Gapminder dataset. Available online at http://www.gapminder.org/."}},"123":{"years":[],"entities":[],"values":[],"id":123,"name":"Countries Continents","unit":"","description":"Countries and their associated continents.","createdAt":"2015-08-19T00:09:40.000Z","updatedAt":"2018-02-28T08:58:29.000Z","code":null,"coverage":"","timespan":"","datasetId":115,"sourceId":44,"shortUnit":null,"display":{},"columnOrder":0,"datasetName":"Countries Continents","s_id":44,"s_name":"Our World In Data","source":{"id":44,"name":"Our World In Data","dataPublishedBy":"","dataPublisherSource":"","link":"","retrievedData":"","additionalInfo":""}},"83469":{"years":[],"entities":[],"values":[],"id":83469,"name":"Prevalence - Attention-deficit/hyperactivity disorder - Sex: Male - Age: Age-standardized (Percent)","unit":"Percent","description":null,"createdAt":"2018-02-11T13:51:56.000Z","updatedAt":"2018-02-28T08:59:26.000Z","code":"5 578 1 27 2","coverage":"","timespan":"","datasetId":2407,"sourceId":14410,"shortUnit":null,"display":{},"columnOrder":0,"datasetName":"Attention-deficit/hyperactivity disorder","s_id":14410,"s_name":"Attention-deficit/hyperactivity disorder","source":{"id":14410,"name":"Attention-deficit/hyperactivity disorder","dataPublishedBy":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2017.","dataPublisherSource":"","link":"http://ghdx.healthdata.org/gbd-results-tool","retrievedData":"","additionalInfo":""}},"83470":{"years":[],"entities":[],"values":[],"id":83470,"name":"Prevalence - Attention-deficit/hyperactivity disorder - Sex: Female - Age: Age-standardized (Percent)","unit":"Percent","description":null,"createdAt":"2018-02-11T13:51:56.000Z","updatedAt":"2018-02-28T08:59:26.000Z","code":"5 578 2 27 2","coverage":"","timespan":"","datasetId":2407,"sourceId":14410,"shortUnit":null,"display":{},"columnOrder":0,"datasetName":"Attention-deficit/hyperactivity disorder","s_id":14410,"s_name":"Attention-deficit/hyperactivity disorder","source":{"id":14410,"name":"Attention-deficit/hyperactivity disorder","dataPublishedBy":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2017.","dataPublisherSource":"","link":"http://ghdx.healthdata.org/gbd-results-tool","retrievedData":"","additionalInfo":""}}},"entityKey":{}}